# A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma

> **NCT02512315** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 192 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Docetaxel (DOC)
- **DRUG:** Cisplatin (DDP)
- **RADIATION:** Concurrent chemoradiation (CCRT)

## Key facts

- **NCT ID:** NCT02512315
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2021-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02512315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02512315, "A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02512315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*